JENKINS GEORGE M enters PALVELLA THERAPEUTICS, INC. with 187.70K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 12/16/2024ACC: 0001062993-24-020694
Director
Since Feb 2026
187.70K
Baseline shares
94% direct
176.67K
Direct ownership
1 position
18.43K
Derivative underlying
2 instruments
2
Security positions
11.03K indirect
Non-Derivative Holdings2
Common Stock
DirectShares owned176.67K
Common Stock
IndirectShares owned11.03K
Total
176.67K direct·11.03K indirect187.70K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 176.67K | Direct |
| Common Stock | 11.03K | Indirect |
| Total | 187.70K | 176.67K direct·11.03K indirect |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
6.96K
Shares owned
N/A
Exercise price
7.14
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
11.46K
Shares owned
N/A
Exercise price
7.53
Expiration
—
Exercise window
—
Total
Underlying
18.43K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 7.14 | — | — | 6.96K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 7.53 | — | — | 11.46K | N/A |
| Total | 18.43K | 0.00 | ||||